reference/26873195

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26873195

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	471
issn	1442-2042 0919-8172
issueIdentifier	5
pageRange	465-471
publicationName	International journal of urology : official journal of the Japanese Urological Association
startingPage	465
bibliographicCitation	Miyake H, Sakai I, Muramaki M, Kurahashi T, Takenaka A, Fujisawa M. Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens. Int J Urol. 2009 May;16(5):465–71. doi: 10.1111/j.1442-2042.2009.02262.x. PMID: 19467119.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc98c43bd24e70b57d72ee50ce0ffcdf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_750e27ff50a198843644793502b2e583 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87a03b162b11b996a593a3af8264ee41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd0cbd719fa3915747abbb4bb053446f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37ef83176a82198a5a9331894abd949a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1721cb12e677c6d0d83ac2e060ee71b9
date	2009-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1111/j.1442-2042.2009.02289.x https://doi.org/10.1111/j.1442-2042.2009.02262.x https://pubmed.ncbi.nlm.nih.gov/19467119
isPartOf	https://portal.issn.org/resource/ISSN/0919-8172 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8739 https://portal.issn.org/resource/ISSN/1442-2042
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens
discusses	http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0011157 http://id.nlm.nih.gov/mesh/M0025711 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0011506
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007376Q000008 http://id.nlm.nih.gov/mesh/D002292Q000188 http://id.nlm.nih.gov/mesh/D007680Q000188 http://id.nlm.nih.gov/mesh/D016898Q000008 http://id.nlm.nih.gov/mesh/D015415Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D014408Q000378 http://id.nlm.nih.gov/mesh/D002292Q000556 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D002292Q000401 http://id.nlm.nih.gov/mesh/D007155Q000008 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D015999 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007680Q000401 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D009392Q000401 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D007680Q000473 http://id.nlm.nih.gov/mesh/D011237 http://id.nlm.nih.gov/mesh/D004359
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e1afa113b0d884f36154ce9339375de8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1b2452da84551fc91db93425b6a20d9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0d1c0203c86182a45fb1c6272bbe1d33 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a7939d043567ee90a9f1febb314e563d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cae1136973304226b6579fdacf6db996 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_19e0fa430b5a0437b87cf5bf7a365011 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.24.35 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.24.24

Total number of triples: 68.